• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Insights into early recovery from Long COVID-results from the German DigiHero Cohort

tetano

Editor, Senior Moderator
Sci Rep


. 2024 Apr 13;14(1):8569.
doi: 10.1038/s41598-024-59122-3. Insights into early recovery from Long COVID-results from the German DigiHero Cohort

Sophie Diexer[SUP] 1 [/SUP], Bianca Klee[SUP] 1 [/SUP], Cornelia Gottschick[SUP] 1 [/SUP], Anja Broda[SUP] 1 [/SUP], Oliver Purschke[SUP] 1 [/SUP], Mascha Binder[SUP] 2 3 [/SUP], Michael Gekle[SUP] 4 [/SUP], Matthias Girndt[SUP] 5 [/SUP], Jessica I Hoell[SUP] 6 [/SUP], Irene Moor[SUP] 7 [/SUP], Daniel Sedding[SUP] 8 [/SUP], Jonas Rosendahl[SUP] 9 [/SUP], Rafael Mikolajczyk[SUP] 10 [/SUP]



Affiliations
Abstract

65 million people worldwide are estimated to suffer from long-term symptoms after their SARS-CoV-2 infection (Long COVID). However, there is still little information about the early recovery among those who initially developed Long COVID, i.e. had symptoms 4-12 weeks after infection but no symptoms after 12 weeks. We aimed to identify associated factors with this early recovery. We used data from SARS-CoV-2-infected individuals from the DigiHero study. Participants provided information about their SARS-CoV-2 infections and symptoms at the time of infection, 4-12 weeks, and more than 12 weeks post-infection. We performed multivariable logistic regression to identify factors associated with early recovery from Long COVID and principal component analysis (PCA) to identify groups among symptoms. 5098 participants reported symptoms at 4-12 weeks after their SARS-CoV-2 infection, of which 2441 (48%) reported no symptoms after 12 weeks. Men, younger participants, individuals with mild course of acute infection, individuals infected with the Omicron variant, and individuals who did not seek medical care in the 4-12 week period after infection had a higher chance of early recovery. In the PCA, we identified four distinct symptom groups. Our results indicate differential risk of continuing symptoms among individuals who developed Long COVID. The identified risk factors are similar to those for the development of Long COVID, so people with these characteristics are at higher risk not only for developing Long COVID, but also for longer persistence of symptoms. Those who sought medical help were also more likely to have persistent symptoms.

Keywords: COVID-19; Long COVID; Post COVID Condition; SARS-CoV-2.

 
Back
Top Bottom